Current evidence of epidermal barrier dysfunction and thymic stromal lymphopoietin in the atopic march

Li Mei

Source: Eur Respir Rev 2014; 23: 292-298
Journal Issue: September
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Li Mei. Current evidence of epidermal barrier dysfunction and thymic stromal lymphopoietin in the atopic march. Eur Respir Rev 2014; 23: 292-298

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Thymic stromal lymphopoietin, but not ezrin, could be an early biomarker of airway epithelial dysfunction in acute allergic asthma
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019

Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: the role of thymic stromal lymphopoietin
Source: International Congress 2018 – Roles of innate lymphoid cells in asthma
Year: 2018


Serum thymic stromal lymphopoietin level depends on allergic profile in pediatric asthma
Source: Virtual Congress 2021 – Paediatric lung disease: novel mechanisms, methods and translational studies
Year: 2021



Blockade of thymic stromal lymphopoietin receptor (TSLPR) reduces atopic inflammation in a cynomolgus monkey model of asthma
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012

Thymic stromal lymphopoietin (TSLP) as a local biomarker of hypertrophic changes in the synonasal mucosa in children with atopic bronchial asthma (BA) and allergic rhinitis (AR)
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021


Peripheral blood TSLP (thymic stromal lymphopoietin) in children as a biomarker?
Source: Virtual Congress 2021 – Biomarkers and risk factors in childhood asthma
Year: 2021


IL-4Ra signaling is required for thymic stromal lymphopoietin (TSLP)-induced type 2 airway inflammation
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021



Thymic stromal lymphopoietin promotes asthmatic airway remodeling in human lung fibroblast cells through stat3 signaling pathway
Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung
Year: 2012

FcepsilonRI-mediated thymic stromal lymphopoietin production by interleukin-4-primed human mast cells
Source: Eur Respir J 2009; 33: 425-435
Year: 2009



Thymic stromal lymphopoietin (TSLP) in naturally occurring asthma exacerbations in adults
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016

Analysing disease-specific variants of thymic stromal lymphopoietin (TSLP) in asthma
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015

Inhaled antibodies: targeting tumour necrosis factor receptor 1 and thymic stromal lymphopoietin
Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments
Year: 2019


Association of thymic stromal lymphopoietin gene polymorphisms with atopic status, pulmonary function and airway hyperresponsiveness in a Japanese adult asthmatic population
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013


Thymic stromal lymphopoietin (TSLP), an innate immunity initiator of Th2 inflammatory responses, is induced by viral stimuli in asthmatic epithelium.
Source: Annual Congress 2008 - New mechanisms in the pathogenesis of asthma and its response to treatment
Year: 2008

Interaction between epithelial cells and sub-epithelial mesenchymal cells in severe non-allergic asthma
Source: International Congress 2019 – Pathophysiology and clinical insights into severe non-allergic asthma
Year: 2019


Suppression of allergic airway inflammation in a mouse model of asthma by exogenous mesenchymal stem cells
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010

Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma
Source: Eur Respir J 2003; 21: 804-809
Year: 2003



Increased immunoreactivity of stromal cell-derived factor-1 and angiogenesis in asthma
Source: Annual Congress 2004 - Inflammation and remodelling in human lungs
Year: 2004


IL-25 secreted from epithelial cells has the potential to promote airway remodeling in asthma
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012

Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype
Source: Eur Respir Rev 2014; 23: 118-130
Year: 2014